[1] Y. Choi, Y. Cho, M. Kim, R. Grailhe, R. Song, "Fluorogenic quantum dot-gold nanoparticle assembly for beta secretase inhibitor screening in live cell," Anal. Chem. 84, 8595–8601 (2012).

[2] H. Mollasalehi, R. Yazdanparast, "Non-crosslinking gold nanoprobes for detection of nucleic acid sequence- based amplification products," Anal. Biochem. 425, 91–95 (2012).

[3] T. pringer, J. Homola, "Biofunctionalized gold nanoparticles for spr-biosensor-based detection of cea in blood plasma," Anal. Bioanal. Chem. 404, 2869–2875 (2012).

[4] D. T. Nguyen, D.-J. Kim, K.-S. Kim, "Controlled synthesis and biomolecular probe application of gold nanoparticles," Micron 42, 207–227 (2011).

[5] S. Keren, C. Zavaleta, Z. Cheng, A. de la Zerda, O. Gheysens, S. S. Gambhir, "Noninvasive molecular imaging of small living subjects using raman spectroscopy," Proc. Natl. Acad. Sci. USA 105, 5844– 5849 (2008).

[6] A. S. Thakor, R. Luong, R. Paulmurugan, F. I. Lin, P. Kempen, C. Zavaleta, P. Chu, T. F. Massoud, R. Sinclair, S. S. Gambhir, "The fate and toxicity of raman active silica-gold nanoparticles in mice," Sci. Translat. Med. 3, doi:10.1126/scitranslmed. 3001963 (2011).

[7] J. V. Jokerst, Z. Miao, C. Zavaleta, Z. Cheng, S. S. Gambhir, "Affibody-functionalized gold–silica nanoparticles for raman molecular imaging of the epidermal growth factor receptor," Small (Weinheim an Der Bergstrasse, Germany) 7, 625–633 (2011).

[8] S.-P. Lee, "Non-alcoholic fatty liver disease, a marker of subclinical atherosclerosis applicable only to metabolic syndrome : Time to organize the connection between metabolism and atherosclerosis," J. Cardiovasc. Ultrasound 20, 124–125 (2012).

[9] S. Lee, H. Chon, J. Lee, J. Ko, B. H. Chung, D. W. Lim, J. Choo, "Rapid and sensitive phenotypic marker detection on breast cancer cells using surface- enhanced raman scattering (sers) imaging," Biosens. Bioelectron. 51, 238–243 (2014).

[10] K. Saha, S. S. Agasti, C. Kim, X. Li, V. M. Rotello, "Gold nanoparticles in chemical and biological sensing," Chem. Rev. 112, 2739–2779 (2012).

[11] X. Wang, Y. Xia, Y. Liu, W. Qi, Q. Sun, Q. Zhao, B. Tang, "Dual-luminophore-labeled gold nanoparticles with completely resolved emission for the simultaneous imaging of mmp-2 and mmp-7 in living cells under single wavelength excitation," Chem. A Eur. J. 18, 7189–7195 (2012).

[12] R. A. Petros, J. M. DeSimone, "Strategies in the design of nanoparticles for therapeutic applications," Nat. Rev. Drug Discov. 9, 615–627 (2010).

[13] H. Lusic, M. W. Grinstaff, "X-ray-computed tomography contrast agents," Chem. Rev. 113, 1641– 1666 (2013).

[14] K. B. Ghaghada, C. T. Badea, L. Karumbaiah, N. Fettig, R. V. Bellamkonda, G. A. Johnson, A. Annapragada, "Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging," Acad. Radiol. 18, 20–30 (2011).

[15] J. F. Hainfeld, M. J. O'Connor, F. A. Dilmanian, D. N. Slatkin, D. J. Adams, H. M. Smilowitz, "Micro-ct enables microlocalisation and quantification of her2- targeted gold nanoparticles within tumour regions," Br. J. Radiol. 84, 526–533 (2011).

[16] H. Wang, L. Zheng, C. Peng, M. Shen, X. Shi, G. Zhang, "Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted ct imaging of human lung adencarcinoma," Biomaterials 34, 470–480 (2013).

[17] T. Reuveni, M. Motiei, Z. Romman, A. Popovtzer, R. Popovtzer, "Targeted gold nanoparticles enable molecular ct imaging of cancer: An in vivo study," Int. J. Nanomed. 6, 2859–2864 (2011).

[18] Q. Chen, H. Wang, H. Liu, S. Wen, C. Peng, M. Shen, G. Zhang, X. Shi, "Multifunctional dendrimer- entrapped gold nanoparticles modified with rgd peptide for targeted computed tomography/ magnetic resonance dual-modal imaging of tumors," Anal. Chem. 87, 3949–3956 (2015).

[19] T. Curry, R. Kopelman, M. Shilo, R. Popovtzer, "Multifunctional theranostic gold nanoparticles for targeted ct imaging and photothermal therapy," Contrast Media Mol. Imag. 9, 53–61 (2014).

[20] J. Li, Y. Hu, J. Yang, P. Wei, W. Sun, M. Shen, G. Zhang, X. Shi, "Hyaluronic acid-modified fe3o4@au core/shell nanostars for multimodal imaging and photothermal therapy of tumors," Biomaterials 38, 10–21 (2015).

[21] Q. Chen, K. Li, S. Wen, H. Liu, C. Peng, H. Cai, M. Shen, G. Zhang, X. Shi, "Targeted ct/mr dual mode imaging of tumors using multifunctional dendrimerentrapped gold nanoparticles," Biomaterials 34, 5200–5209 (2013).

[22] K. Li, S. Wen, A. C. Larson, M. Shen, Z. Zhang, Q. Chen, X. Shi, G. Zhang, "Multifunctional dendrimer- based nanoparticles for in vivo mr/ct dualmodal molecular imaging of breast cancer," Int. J. Nanomed. 8, 2589–2600 (2013).

[23] L. Karmani, D. Labar, V. Valembois, V. Bouchat, P. G. Nagaswaran, A. Bol, J. Gillart, P. Levêque, C. Bouzin, D. Bonifazi, C. Michiels, O. Feron, V. Gregoire, S. Lucas, T. V. Borght, B. Gallez, "Antibody-functionalized nanoparticles for imaging cancer: Influence of conjugation to gold nanoparticles on the biodistribution of 89zr-labeled cetuximab in mice," Contrast Media Mol. Imag. 8, 402–408 (2013).

[24] L. Karmani, V. Bouchat, C. Bouzin, P. Levêque, D. Labar, A. Bol, G. Deumer, R. Marega, D. Bonifazi, V. Haufroid, C. Michiels, V. Gregoire, O. Feron, S. Lucas, T. Vander Borght, B. Gallez, "89zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: Implications for future cancer therapy," Nanomedicine 9, 1923–1937 (2014).

[25] Y. Zhao, D. Sultan, L. Detering, H. Luehmann, Y. Liu, "Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of 64cu-au alloy nanoclusters," Nanoscale 6, 13501–13509 (2014).

[26] Y. Zhao, D. Sultan, L. Detering, S. Cho, G. Sun, R. Pierce, K. L. Wooley, Y. Liu, "Copper-64-alloyed gold nanoparticles for cancer imaging: Improved radiolabel stability and diagnostic accuracy," Angew. Chem. Int. Ed. 53, 156–159 (2014).

[27] H. Groult, J. Ruiz-Cabello, J. Pellico, A. V. Lechuga-Vieco, R. Bhavesh, M. Zamai, E. Almarza, I. Martín-Padura, E. Cantelar, M. P. Martínez- Alcazar, F. Herranz, "Parallel multifunctionalization of nanoparticles: A one-step modular approach for in vivo imaging," Bioconjugate Chem. 26, 153–160 (2015).

[28] K. C. L. Black, Y. Wang, H. P. Luehmann, X. Cai, W. Xing, B. Pang, Y. Zhao, C. S. Cutler, L. V. Wang, Y. Liu, Y. Xia, "Radioactive 198au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution," ACS Nano 8, 4385–4394 (2014).

[29] Y. Wang, Y. Liu, H. Luehmann, X. Xia, D. Wan, C. Cutler, Y. Xia, "Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging," Nano Lett. 13, 581–585 (2013).

[30] K. Y. Choi, G. Liu, S. Lee, X. Chen, "Theranostic nanoplatforms for simultaneous cancer imaging and therapy: Current approaches and future perspectives," Nanoscale 4, 330–342 (2012).

[31] H.-C. Huang, S. Barua, G. Sharma, S. K. Dey, K. Rege, "Inorganic nanoparticles for cancer imaging and therapy," J. Control. Release 155, 344–357 (2011).

[32] J. Choi, J. Yang, D. Bang, J. Park, J.-S. Suh, Y.-M. Huh, S. Haam, "Targetable gold nanorods for epithelial cancer therapy guided by near-ir absorption imaging," Small 8, 746–753 (2012).

[33] S.-H. Seo, B.-M. Kim, A. Joe, H.-W. Han, X. Chen, Z. Cheng, E.-S. Jang, "Nir-light-induced surfaceenhanced raman scattering for detection and photothermal/ photodynamic therapy of cancer cells using methylene blue-embedded gold nanorod@sio2 nanocomposites," Biomaterials 35, 3309–3318 (2014).

[34] N. Jimenez-Mancilla, G. Ferro-Flores, C. Santos- Cuevas, B. Ocampo-García, M. Luna-Gutierrez, E. Azorín-Vega, K. Isaac-Olive, M. Camacho-López, E. Torres-García, "Multifunctional targeted therapy system based on 99mtc/177lu-labeled gold nanoparticles- tat(49–57)-lys3-bombesin internalized in nuclei of prostate cancer cells," J. Label. Comp. Radiopharm. 56, 663–671 (2013).

[35] M. Raoof, S. J. Corr, W. D. Kaluarachchi, K. L. Massey, K. Briggs, C. Zhu, M. A. Cheney, L. J. Wilson, S. A. Curley, "Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: Implications for noninvasive radiofrequency-based cancer therapy," Nanomed. Nanotechnol. Biol. Med. 8, 1096–1105 (2012).

[36] J. Lin, S. Wang, P. Huang, Z. Wang, S. Chen, G. Niu, W. Li, J. He, D. Cui, G. Lu, X. Chen, Z. Nie, "Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/ photodynamic therapy," ACS Nano 7, 5320–5329 (2013).

[37] V. Biju, "Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy," Chem. Soc. Rev. 43, 744–764 (2014).

[38] E. Jeong, G. Jung, C. Hong, H. Lee, "Gold nanoparticle (aunp)-based drug delivery and molecular imaging for biomedical applications," Arch. Pharm. Res. 37, 53–59 (2014).

[39] H. Jaganathan, S. Mitra, S. Srinivasan, B. Dave, B. Godin, "Design and in vitro evaluation of layer by layer sirna nanovectors targeting breast tumor initiating cells," PLoS ONE 9, e91986 (2014).

[40] J. Conde, A. Ambrosone, V. Sanz, Y. Hernandez, V. Marchesano, F. Tian, H. Child, C. C. Berry, M. R. Ibarra, P. V. Baptista, C. Tortiglione, J. M. de la Fuente, "Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing," ACS Nano 6, 8316–8324 (2012).

[41] A. Ekin, O. F. Karatas, M. Culha, M. Ozen, "Designing a gold nanoparticle-based nanocarrier for microrna transfection into the prostate and breast cancer cells," J. Gene Med. 16, 331–335 (2014).

[42] J.-H. Yeom, S.-M. Ryou, M. Won, M. Park, J. Bae, K. Lee, "Inhibition of xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugatesassisted delivery of bax mrna," PLoS ONE 8, e75369 (2013).

[43] S. Huo, S. Jin, X. Ma, X. Xue, K. Yang, A. Kumar, P. C. Wang, J. Zhang, Z. Hu, X.-J. Liang, "Ultrasmall gold nanoparticles as carriers for nucleus- based gene therapy due to size-dependent nuclear entry," ACS Nano 8, 5852–5862 (2014).

[44] C. J. Bishop, S. Y. Tzeng, J. J. Green, "Degradable polymer-coated gold nanoparticles for co-delivery of DNA and sirna," Acta Biomater. 11, 393–403 (2015).

[45] L. Han, J. Zhao, X. Zhang, W. Cao, X. Hu, G. Zou, X. Duan, X.-J. Liang, "Enhanced sirna delivery and silencing gold–chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility," ACS Nano 6, 7340–7351 (2012).

[46] A. Llevot, D. Astruc, "Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer," Chem. Soc. Rev. 41, 242–257 (2012).

[47] Y. Cheng, T. L. Doane, C.-H. Chuang, A. Ziady, C. Burda, "Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy," Small 10, 1799–1804 (2014).

[48] S. Rana, A. Bajaj, R. Mout, V. M. Rotello, "Monolayer coated gold nanoparticles for delivery applications," Adv. Drug Deliv. Rev. 64, 200–216 (2012).

[49] A. S. Thakor, J. Jokerst, C. Zavaleta, T. F. Massoud, S. S. Gambhir, Gold nanoparticles: A revival in precious metal administration to patients," Nano Lett. 11, 4029–4036 (2011).

[50] N. C. Bigall, A. Curcio, M. P. Leal, A. Falqui, D. Palumberi, R. Di Corato, E. Albanesi, R. Cingolani, T. Pellegrino, "Magnetic nanocarriers with tunable ph dependence for controlled loading and release of cationic and anionic payloads," Adv. Mat. 23, 5645– 5650 (2011).

[51] C. M. Dawidczyk, C. Kim, J. H. Park, L. M. Russell, K. H. Lee, M. G. Pomper, P. C. Searson, "State-ofthe- art in design rules for drug delivery platforms: Lessons learned from fda-approved nanomedicines," J. Control. Release 187, 133–144 (2014).

[52] S. C. Coelho, S. Rocha, P. Juzenas, P. Sampaio, G. M. Almeida, F. S. Silva, M. C. Pereira, M. A. N. Coelho, "Gold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cells," Expert Opin. Drug Deliv. 10, 1345–1352 (2013).

[53] A. Latorre, C. Posch, Y. Garcimartin, A. Celli, M. Sanlorenzo, I. Vujic, J. Ma, M. Zekhtser, K. Rappersberger, S. Ortiz-Urda, A. Somoza, "DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics," Nanoscale 6, 7436–7442 (2014).

[54] Y.-S. Shiao, H.-H. Chiu, P.-H. Wu, Y.-F. Huang, "Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery," ACS Appl. Mat. Interfaces 6, 21832–21841 (2014).

[55] S.-M. Ryou, J.-H. Yeom, H. J. Kang, M. Won, J.-S. Kim, B. Lee, M.-J. Seong, N.-C. Ha, J. Bae, K. Lee, "Gold nanoparticle–DNA aptamer composites as a universal carrier for in vivo delivery of biologically functional proteins," J. Control. Release 196, 287– 294 (2014).

[56] X. Sun, G. Zhang, R. S. Keynton, M. G. O'Toole, D. Patel, A. M. Gobin, "Enhanced drug delivery via hyperthermal membrane disruption using targeted gold nanoparticles with pegylated protein-g as a cofactor," Nanomed. Nanotechnol. Biol. Med. 9, 1214–1222 (2013).

[57] S. Biswas, S. H. Medina, J. J. Barchi Jr., "Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigencoated gold nanoparticles," Carbohydrate Res. 405, 93–101 (2015).

[58] A. Kumar, S. Huo, X. Zhang, J. Liu, A. Tan, S. Li, S. Jin, X. Xue, Y. Zhao, T. Ji, L. Han, H. Liu, X. Zhang, J. Zhang, G. Zou, T. Wang, S. Tang, X.-J. Liang, "Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(iv) drug for prostate cancer treatment," ACS Nano 8, 4205– 4220 (2014).

[59] M. S. Mohamed, S. Veeranarayanan, A. C. Poulose, Y. Nagaoka, H. Minegishi, Y. Yoshida, T. Maekawa, D. S. Kumar, "Type 1 ribotoxin-curcin conjugated biogenic gold nanoparticles for a multimodal therapeutic approach towards brain cancer," Biochim. Biophys. Acta Gen. Subj. 1840, 1657–1669 (2014).

[60] W. Pan, H. Yang, T. Zhang, Y. Li, N. Li, B. Tang, "Dual-targeted nanocarrier based on cell surface receptor and intracellular mrna: An effective strategy for cancer cell imaging and therapy," Anal. Chem. 85, 6930–6935 (2013).

[61] Y. Wang, Z. Miao, G. Ren, Y. Xu, Z. Cheng, "A novel affibody bioconjugate for dual-modality imaging of ovarian cancer," Chem. Commun. 50, 12832–12835 (2014).

[62] M. S. Khan, G. D. Vishakante, H. Siddaramaiah, "Gold nanoparticles: A paradigm shift in biomedical applications," Adv. Colloid Interface Sci. 199–200, 44–58 (2013).

[63] Y. Wang, K. C. L. Black, H. Luehmann, W. Li, Y. Zhang, X. Cai, D. Wan, S.-Y. Liu, M. Li, P. Kim, Z.-Y. Li, L. V. Wang, Y. Liu, Y. Xia, "Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment," ACS Nano 7, 2068–2077 (2013).

[64] Z. Heidari, R. Sariri, M. Salouti, "Gold nanorodsbombesin conjugate as a potential targeted imaging agent for detection of breast cancer," J. Photochem. Photobiol. B: Biol. 130, 40–46 (2014).

[65] K. Cheng, S.-R. Kothapalli, H. Liu, A. L. Koh, J. V. Jokerst, H. Jiang, M. Yang, J. Li, J. Levi, J. C. Wu, S. S. Gambhir, Z. Cheng, "Construction and validation of nano gold tripods for molecular imaging of living subjects," J. Am. Chem. Soc. 136, 3560–3571 (2014).